Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) Files An 8-K Results of Operations and Financial Condition

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) Files An 8-K Results of Operations and Financial Condition
Item 2.02 by reference to Exhibit 99.1, are being furnished, and shall not be deemed “filed,” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Story continues below

Item 2.02

Results of Operations and Financial Condition

On December 15, 2017, Ohr Pharmaceutical, Inc., a Delaware corporation, issued a press release announcing its results for the fiscal year ended September 30, 2017. This press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)Exhibits:

99.1 Press release, dated December 15, 2017


Ohr Pharmaceutical Inc Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE   Ohr Pharmaceutical,…
To view the full exhibit click here

An ad to help with our costs